Maha Hussain

Publications

3 shown

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Christos E. Kyriakopoulos , Yu‐Hui Chen , Michael A. Carducci +15 more

Purpose Docetaxel added to androgen-deprivation therapy (ADT) significantly increases the longevity of some patients with metastatic hormone-sensitive prostate cancer. Herein, w...

2018 Journal of Clinical Oncology 1049 citations

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

Maha Hussain , Karim Fizazi , Fred Saad +9 more

Among men with nonmetastatic, castration-resistant prostate cancer with a rapidly rising PSA level, enzalutamide treatment led to a clinically meaningful and significant 71% low...

2018 New England Journal of Medicine 1003 citations

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak , Catherine M. Tangen , Maha Hussain +11 more

The improvement in median survival of nearly two months with docetaxel and estramustine, as compared with mitoxantrone and prednisone, provides support for this approach in men ...

2004 New England Journal of Medicine 3663 citations

Researcher Info

h-index: 3
Publications: 3
Citations: 5,715
Institution: Dana-Farber Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-0380-9465

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.

Publications

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Frequent Co-Authors

Christos E. Kyriakopoulos

Yu‐Hui Chen

Michael A. Carducci

Glenn Liu

David F. Jarrard

Noah M. Hahn

Researcher Info

External Links

Identifiers

Impact Metrics